Truist Securities Comments on Centessa Pharmaceuticals (CNTA) Amid 18pct Drop
Tweet Send to a Friend
Truist Securities analyst Danielle Brill reiterated a Buy rating and $30.00 price target on Centessa Pharmaceuticals (NASDAQ: CNTA).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
